Neogenomics Inc
NEO8.620USD
+0.510+6.29%
收盤 09/18, 16:00（美東）報價延遲15分鐘
1.11B總市值
虧損本益比TTM
關於 Neogenomics Inc 公司
NeoGenomics, Inc. 提供一系列腫瘤診斷測試和諮詢服務，包括技術實驗室服務。該公司由專門從事病理學和腫瘤學的執業醫師提供對實驗室測試結果的專業解釋。其部門包括臨牀服務和高級診斷。臨牀服務部門包括臨牀癌症檢測；解釋和諮詢服務；分子和 NGS 檢測，以及全面的技術和專業服務。其臨牀服務客戶包括社區病理學和腫瘤學診所、醫院病理學實驗室、參考實驗室和學術中心。高級診斷部門包括臨牀試驗和研究、驗證實驗室服務和信息學。其高級診斷客戶包括製藥公司，該公司爲其提供測試和其他服務以支持其研究和臨牀試驗。
公司簡介
公司代碼NEO
公司名稱Neogenomics Inc
上市日期Dec 10, 2012
CEOMr. Antony P. Zook
員工數量2200
證券類型Ordinary Share
年結日Dec 10
公司地址9490 Neogenomics Way
城市FORT MYERS
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編33912
電話12397680600
網址https://neogenomics.com/
公司代碼NEO
上市日期Dec 10, 2012
CEOMr. Antony P. Zook
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. Antony P. Zook
Mr. Antony P. Zook
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
--
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Clinical Services-Client direct billing
122.04M
72.63%
Clinical Services-Commercial Insurance
24.86M
14.79%
Clinical Services-Medicare and Medicaid
21.10M
12.56%
Clinical Services-Self-Pay
39.00K
0.02%
股東統計
更新時間: 8月15日 週五
更新時間: 8月15日 週五
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
其他
60.32%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.76%
The Vanguard Group, Inc.
10.92%
Greenhouse Funds LLLP
5.75%
First Light Asset Management, LLC
5.30%
State Street Global Advisors (US)
3.96%
其他
60.32%
股東類型
持股股東
佔比
Investment Advisor
50.14%
Investment Advisor/Hedge Fund
31.89%
Hedge Fund
14.04%
Research Firm
2.36%
Individual Investor
1.29%
Pension Fund
1.17%
Bank and Trust
0.61%
Sovereign Wealth Fund
0.09%
Family Office
0.05%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
2023Q1
704
120.14M
94.21%
-27.80M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
18.29M
14.21%
-356.84K
-1.91%
Mar 31, 2025
The Vanguard Group, Inc.
14.23M
11.06%
+17.23K
+0.12%
Mar 31, 2025
Greenhouse Funds LLLP
4.71M
3.66%
+6.43K
+0.14%
Mar 31, 2025
First Light Asset Management, LLC
6.04M
4.7%
+2.88M
+90.77%
Mar 31, 2025
State Street Global Advisors (US)
5.09M
3.95%
-109.12K
-2.10%
Mar 31, 2025
Macquarie Investment Management
4.68M
3.63%
+864.39K
+22.67%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.85M
2.99%
+408.27K
+11.88%
Mar 31, 2025
Schroder Investment Management North America Inc.
4.31M
3.35%
+509.99K
+13.42%
Mar 31, 2025
American Century Investment Management, Inc.
3.32M
2.58%
+426.34K
+14.74%
Mar 31, 2025
Millennium Management LLC
6.72M
5.22%
+5.29M
+371.20%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
